Obesity Phenotypes and Its Relation to Cardiovascular Diseases

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06092021
Collaborator
(none)
200
1
14
14.3

Study Details

Study Description

Brief Summary

To determine the association between obesity phenotypes with cardiovascular diseases.

  • Primary Outcomes:

1- To examine the association between different obesity phenotypes and cardiovascular diseases.by using echocardiography, lipid profile

  • Secondary Outcomes:
  1. frequency of obesity phenotypes on our locality

  2. Correlation between each type of obesity phenotypes and other metabolic disturbances (e.g. DM, dyslipidemia, NASH)

  3. Correlation between epcardial fat, carotid intimal thickness and different obesity phenotypes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Obesity is a condition caused by increasing the fat components of body resulting in body weight increase. Obesity leads to several complications like type 2 diabetes, hypertension and cardiovascular events, sleep apnea. But obesity can no longer be evaluated solely by the body mass index (expressed in kg/m2) because it represents a heterogeneous entity (1). As there are several cardio-metabolic imaging studies have shown that some individuals who have a normal weight or who are overweight are at high risk if they have an excess of visceral adipose tissue-a condition often accompanied by accumulation of fat in normally lean tissues (ectopic fat deposition in liver, heart, skeletal muscle, etc.) (2) On the other hand, individuals who are overweight or obese can nevertheless be at much lower risk than expected when faced with excess energy intake if they have the ability to expand their subcutaneous adipose tissue mass, particularly in the gluteal-femoral area, as preferential fat storage in the lower body depot may act as a metabolic buffer and protect other tissues from lipotoxicity caused by lipid overflow and ectopic fat (3). Hence, excessive amounts of visceral adipose tissue and of ectopic fat largely define the cardiovascular disease risk of overweight and moderate obesity (4). Epicardial fat is considered as indicator of cardiovascular risk. Several studies have tested the association between epicardial fat thickness (EFT) and coronary artery disease many studies stated that epicardial fat is independently and linearly associated with CAD and its severity .In this study we aim to monitor the extent of obesity phenotypes association to cardiovascular diseases in patients attending to Obesity Clinic in Assuit Hospital University.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Other
    Time Perspective:
    Cross-Sectional
    Official Title:
    Obesity Phenotypes and Its Relation to Cardiovascular Diseases
    Anticipated Study Start Date :
    Oct 1, 2023
    Anticipated Primary Completion Date :
    Oct 1, 2024
    Anticipated Study Completion Date :
    Dec 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. To examine the association between different obesity phenotypes and cardiovascular by using lipid profile and echocardiography [One year]

      Using echocardiography and lipid profile to determine the relationship between obesity and cardiovascular diseases in obese and non obese people

    2. Assess carotid artery elasticity in obese by using echocardiography [One year]

      Find out the effect of cardiovascular diseases and obesity on carotid artery elasticity and atherosclerosis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Adult patient of 18 years old and above
    Exclusion Criteria:
    • 1- Patients below 18 years old age (pediatrics and Child).

    2- Pregnant females.

    3- Patients with congenital heart diseases.

    4- Patients with previous bariatric surgery.

    5-Patients with type 1 DM.

    6-Patients with hereditary hyperlipidemia

    .Secondary causes of obesity

    include these:Endocrine DisordersCushing SyndromeHypothyroidismPseudohypoparathyroidismType 2 diabetes

    Genetic SyndromesPrader-Willi syndromeBardet-Biedel syndromeCohen syndromeCentral Nervous System DisordersHypothalamic TumorTrauma to or inflammation of the hypothalamic regionOtherDrug induced - atypical anti-psychotics, tricyclic antidepressantsBinge eating disorderBulimia nervosa

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Asmaa khaled sayed Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: Asmaa Sayed, Resident, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Asmaa Khaled Sayed, Asmaa khaled sayed, Assiut University
    ClinicalTrials.gov Identifier:
    NCT06092021
    Other Study ID Numbers:
    • Cardiovascular obesity
    First Posted:
    Oct 23, 2023
    Last Update Posted:
    Oct 23, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Asmaa Khaled Sayed, Asmaa khaled sayed, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 23, 2023